The new I-Corps Northeast Hub, of which Rutgers, The State University of New Jersey is a key partner, announced its first researcher training program and is now accepting applications.
A Rutgers professor’s novel research into targeting and silencing defective, disease-causing RNA molecules has led to the launch of Ceptur Therapeutics, a startup that has raised $75 million in Series A funding.
As a key player in developing and transforming innovators into entrepreneurs that improve people’s lives, Rutgers, The State University of New Jersey will expand its entrepreneurship training programming and further equip faculty and student researchers with the skills and strategy needed to transition their discoveries into technologies and products, as a partner in the newly created NSF I-Corps™ Hub: Northeast Region.
Universities play an important role in inspiring diversity among new generations of entrepreneurs and innovators to improve the innovation ecosystem. Providing underrepresented researchers with access to opportunities and networks can bring the needed change to better reflect the diversity of our nation and to tip the scale toward equity and inclusion in innovation.